Exabis Library
Welcome to the e-CCO Library!
P104: Rebamipide, sucralfate, and rifaximin have the suppressive effects on radiation-induced inflammation in the intestine of mouse
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P104: Risk factors associated with the negativisation of anti-HBs antibodies in inflammatory bowel disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P105 Glutathione S -transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P105: An experimental examination of appetite and disordered eating in Crohn's disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P105: Can patients enter the ‘Standard Set’ ICHOM parameters by completing electronic questionnaires?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P105: Coping in Inflammatory Bowel Disease: insights from the Crohn’s and Colitis UK national survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P105: Epithelial microRNA signatures as potential biomarkers in Crohn's disease related to clinical and endoscopic activity
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P105: Human neutrophil elastase degrades the therapeutic monoclonal antibodies effective in IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P105: Inhibition of cytokine release from HT-29 cells and ulcerative colitis biopsies is potentiated by combination of selective kinase inhibitors, and such effects are mimicked by TOP1210, a narrow spectrum kinase inhibitor
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P105: Treatment of the lower gastrointestinal tract Klebsiella infections by recombinant bacteriocin KvarIa
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P106 Depressive symptoms and anxiety and their screening in IBD patients: performance of the distress thermometer in Italian IBD patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P106: Bifidobacterium longum subsp. longum microbiota-secreted bioactive peptide as a novel immunomodulatory compound in the human gastrointestinal tract
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P106: Binding properties of human TLR-9 receptor to cobitolimod – a candidate for treatment of active ulcerative colitis in late stage of clinical development
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P106: Cromoendoscopy versus second generation Narrow band Imaging for dysplasia detection in IBD. An interim analysis of a prospective randomized control trial.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P106: Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P106: Macrophages as a source of NOTCH Ligands in Crohn's disease: implications in fibrosis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P106: Maintenance treatment with granulocyte/monocyte adsorption in patients with inflammatory bowel disease and an initial response to treatment: a Swedish long-term prospective registry study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P106: Successful outcome of the transitional process of inflammatory bowel disease from paediatric to adult age: a 5-year experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P107 The expression and regulation of Oncostatin M and its receptor in intestinal inflammation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P107: Decreased epithelial keratinization contributes to defective wound healing in Crohn's disease fistula
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM